Tetrahydroberberrubine retards heart aging in mice by promoting PHB2-mediated mitophagy
Authors:
- 10 August 2022
- journal article
- research article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 44 (2) , 332-344
Abstract
Heart aging is characterized by left ventricular hypertrophy and diastolic dysfunction, which in turn induces a variety of cardiovascular diseases. There is still no therapeutic drug to ameliorate cardiac abnormities in heart aging. In this study we investigated the protective effects of berberine (BBR) and its derivative tetrahydroberberrubine (THBru) against heart aging process. Heart aging was induced in mice by injection of D-galactose (D-gal, 120 mg · kg−1 · d−1, sc.) for 12 weeks. Meanwhile the mice were orally treated with berberine (50 mg · kg−1 · d−1) or THBru (25, 50 mg · kg−1 · d−1) for 12 weeks. We showed that BBR and THBru treatment significantly mitigated diastolic dysfunction and cardiac remodeling in D-gal-induced aging mice. Furthermore, treatment with BBR (40 μM) and THBru (20, 40 μM) inhibited D-gal-induced senescence in primary neonatal mouse cardiomyocytes in vitro. Overall, THBru exhibited higher efficacy than BBR at the same dose. We found that the levels of mitophagy were significantly decreased during the aging process in vivo and in vitro, THBru and BBR promoted mitophagy with different potencies. We demonstrated that the mitophagy-inducing effects of THBru resulted from increased mRNA stability of prohibitin 2 (PHB2), a pivotal factor during mitophagy, thereby upregulating PHB2 protein expression. Knockdown of PHB2 effectively reversed the antisenescence effects of THBru in D-gal-treated cardiomyocytes. On the contrary, overexpression of PHB2 promoted mitophagy and retarded cardiomyocyte senescence, as THBru did. In conclusion, this study identifies THBru as a potent antiaging medicine that induces PHB2-mediated mitophagy and suggests its clinical application prospects.Keywords
This publication has 65 references indexed in Scilit:
- Berberine Hydrochloride Prevents Postsurgery Intestinal Adhesion and Inflammation in RatsThe Journal of Pharmacology and Experimental Therapeutics, 2014
- Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection FractionJACC: Heart Failure, 2014
- Regio- and enantio-selective glycosylation of tetrahydroprotoberberines by Gliocladium deliquescens NRRL1086 resulting in unique alkaloidal glycosidesApplied Microbiology and Biotechnology, 2011
- Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubineBioorganic & Medicinal Chemistry, 2010
- 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse modelsBioorganic & Medicinal Chemistry, 2010
- Discovery of a Proneurogenic, Neuroprotective ChemicalCell, 2010
- Prohibitin and mitochondrial biologyTrends in Endocrinology & Metabolism, 2009
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex IDiabetes, 2008
- Autophagy: process and functionGenes & Development, 2007